CochLear Competitors

Pink Sheets . USA . 
Stock . CochLear Ltd ADR
CHEOY Stock  USD 93.99  3.59  3.68%   
Analyzing CochLear competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of CochLear to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out CochLear Correlation with its peers.

CochLear vs AI/ML Innovations Correlation

Very weak diversification

The correlation between CochLear Ltd ADR and AIMLF is 0.49 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding CochLear Ltd ADR and AIMLF in the same portfolio, assuming nothing else is changed.

Moving against CochLear Pink Sheet

  0.61TLKMF Telkom Indonesia TbkPairCorr
  0.59PPERY Bank Mandiri Persero Earnings Call This WeekPairCorr
  0.5EW Edwards Lifesciences CorpPairCorr
  0.44ABT Abbott LaboratoriesPairCorr
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
92.5993.9995.39
Details
Intrinsic
Valuation
LowRealHigh
91.2992.6994.09
Details
Naive
Forecast
LowNextHigh
95.4996.9098.30
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
83.5189.9496.37
Details

CochLear Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between CochLear and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of CochLear and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of CochLear ADR does not affect the price movement of the other competitor.

High positive correlations

AIMLF
+ 0.8
NGMDF
IMTH
+ 0.78
NGMDF
GVDI
+ 0.75
IMTH
AIMLF
+ 0.74
IMTH
PHRRF
+ 0.72
IMTH
NGMDF
+ 0.65
ODYY
  

High negative correlations

GVDI
- 0.72
PMSNF
PMSNF
- 0.69
IMTH
PMSNF
- 0.56
PHRRF
AIMLF
- 0.5
ADMT
AIMLF
- 0.49
PMSNF
PMSNF
- 0.45
NGMDF

Risk-Adjusted Indicators

There is a big difference between CochLear Pink Sheet performing well and CochLear Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze CochLear's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ODYY  6.55  0.34  0.05  0.15  7.07 
(10.40)
 14.29 
(12.50)
 100.78 
NGMDF  0.87 (0.38) 0.00  37.30  0.00 
 0.00 
 0.00 
 0.00 
 18.63 
ADMT  6.64  0.47  0.03  0.77  7.79 
(15.14)
 22.22 
(18.18)
 40.40 
IMTH  11.72 (0.80) 0.00  0.52  0.00 
 0.00 
 28.62 
(36.25)
 246.96 
PHRRF  4.14 (0.10) 0.00  0.16  0.00 
 0.00 
 7.50 
(8.33)
 48.18 
PMSNF  8.98  3.25  0.00  0.82  0.00 
 0.00 
 0.00 
 0.00 
 300.00 
CHMMF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
GVDI  0.15 (0.01) 0.00 (0.12) 0.00 
 0.00 
 0.00 
 0.00 
 9.76 
AIMLF  5.10 (0.36) 0.00 (8.12) 0.00 
 0.00 
 12.84 
(14.58)
 35.98 

CochLear Competitive Analysis

The better you understand CochLear competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, CochLear's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across CochLear's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
CHEOY ODYY NGMDF ADMT IMTH PHRRF PMSNF CHMMF GVDI AIMLF
 3.68 
 93.99 
CochLear
 1.35 
 0.07 
Odyssey
 0.00 
 0.03 
NuGen
 18.18 
 0.09 
Adm
 92.17 
 0 
Fresh
 5.07 
 0.07 
Pharmather
 0.00 
 0.04 
Proteome
 0.00 
 0 
Chimeric
 0.00 
 0.02 
Golden
 3.79 
 0.03 
AI/ML
Market Volatility
(90 Days Market Risk)
Very steady
Out of control
Out of control
Out of control
Out of control
Out of control
Out of control
Very steady
Out of control
Out of control
Market Performance
(90 Days Performance)
Weakest
Soft
Weakest
Soft
Weakest
Weakest
Fair
Weakest
Weakest
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Risky
High
Small
Low
Strong
Strong
High
Small
Low
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Over Valued
Fairly Valued
Over Valued
Fairly Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Hold
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Hold
Strong Sell
Strong Sell
Strong Sell
Current Ratio
2.52
0.12
0.45
1.67
0.13
70.26
0.45
N/A
N/A
0.59
Net Asset
2.47 B
569.68 K
8.84 M
3.25 M
4.8 M
12.16 M
10.04 M
34.88 M
53.18 M
2.04 M
Profit Margin
0.18
N/A
N/A
-0.34
N/A
N/A
0.0875
N/A
N/A
N/A
EBITDA
475.4 M
(7.61 M)
(5.09 M)
(325.23 K)
(17.98 M)
(4.1 M)
625 K
(14.14 M)
(73.56 K)
(3.44 M)
Operating Margin
0.23
N/A
-29.06
-0.13
-13.86
N/A
0.15
-5.57
N/A
-8.32
Current Valuation
9.05 B
12.08 M
7.67 M
4.86 M
28.59 M
(3.24 M)
25.13 M
56.81 K
82.18 K
2.1 M
Price To Book
8.15
0.77
9.94
2.86
N/A
0.57
N/A
1.49
N/A
5.3
Retained Earnings
304 M
N/A
N/A
(37.09 M)
N/A
N/A
(68 M)
N/A
(1.89 M)
N/A
Current Asset
543 M
N/A
N/A
2.87 M
N/A
N/A
2 M
N/A
4.22 M
N/A
Five Year Return
1.39
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Beta
0.43
-0.47
N/A
-0.14
-0.0739
2.98
0.0015
N/A
-10.77
1.06
Number Of Employees
4.5 K
4
4
2
40
3
27
7
4
4
Shares Outstanding
131.56 M
75.59 M
96.56 M
67.59 M
21.16 M
88.17 M
295.18 M
437.09 M
12
36.69 M
Cash Flow From Operations
376.5 M
(3.18 M)
(4.1 M)
(574.95 K)
(582.88 K)
(3.51 M)
793 K
(13.15 M)
(810.51 K)
(3.02 M)
Annual Yield
0.0141
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.0439
N/A
Total Debt
253.9 M
1.56 M
5.61 M
11.7 K
350 K
N/A
11.68 M
N/A
149.48 K
40 K
Return On Equity
0.17
-0.35
-14.72
-0.57
N/A
-0.63
N/A
-0.63
N/A
-5.08
Z Score
22.8
-39.3
0.6
N/A
25.5
N/A
-7.8
N/A
N/A
25.5
Return On Asset
0.0973
-6.08
-0.42
-0.0719
-2.48
-0.25
0.06
-0.26
-38.45
-0.6
Book Value Per Share
12.81
-0.075
-0.012
0.025
-0.11
0.088
-0.009
0.06
-0.021
0.009
Current Liabilities
251 M
N/A
N/A
1.06 M
N/A
N/A
9 M
N/A
5.51 M
N/A
Total Asset
2.47 B
569.68 K
8.84 M
3.25 M
4.8 M
12.16 M
10.04 M
34.88 M
53.18 M
2.04 M
Debt To Equity
0.15
0.056
7.4
0.59
N/A
N/A
N/A
N/A
N/A
1.82
Last Dividend Paid
3.0
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
N/A
N/A
N/A
N/A
N/A
0.057
22.89
N/A
N/A
N/A
Market Capitalization
9.71 B
9.64 M
5.74 M
5.14 M
20.73 M
13.44 M
14.76 M
26.23 M
3
1.95 M
Price To Earning
49.26
N/A
N/A
28.98
N/A
2.26
50.0
N/A
-0.02
0.31
Price To Sales
5.55
N/A
13.04
1.34
19.37
N/A
2.31
10.02
0.0751
14.66
Net Income
289.1 M
(8.44 M)
(7.11 M)
(1.38 M)
(18.06 M)
(4.01 M)
72 K
(15.9 M)
(2.57 M)
(3.17 M)
Earnings Per Share
1.53
-0.1
-0.076
-0.009
-0.089
-0.041
N/A
N/A
-0.019
0.13
Shares Owned By Insiders
N/A
27.53
19.15
44.49
62.84
18.67
21.49
47.75
N/A
12.35
Revenue
1.65 B
N/A
137.65 K
3.21 M
1.3 M
N/A
5.13 M
2.62 M
6.99 M
65.41 K
Working Capital
292 M
N/A
N/A
1.81 M
N/A
N/A
(7 M)
N/A
(1.29 M)
N/A
Cash And Equivalents
629.3 M
266.3 K
87.48 K
887.55 K
301.34 K
10.15 M
3.2 M
N/A
827
294.31 K
Cash Per Share
4.78
N/A
N/A
0.01
0.01
0.12
0.01
N/A
N/A
0.01
Gross Profit
1.24 B
N/A
47.3 K
1.25 M
(373.41 K)
N/A
2.96 M
2.62 M
N/A
65.41 K
Day Typical Price
93.99
0.0712
0.025
0.083
0.0022
0.0666
0.04
0.001
0.02
0.0258
Accumulation Distribution
N/A
2570.14
N/A
0.23
N/A
1529.75
N/A
N/A
N/A
4786.69
Market Facilitation Index
N/A
N/A
N/A
0.0211
N/A
N/A
N/A
N/A
N/A
N/A
Daily Balance Of Power
0
(0.19)
0.0
(0.95)
0
(1.03)
0.0
0.0
0.0
(0.83)
Period Momentum Indicator
(3.59)
(0)
N/A
(0.02)
(0.03)
(0)
N/A
N/A
N/A
(0)
Rate Of Daily Change
0.96
0.99
1.0
0.82
0.0783
0.95
1.0
1.0
1.0
0.96
Day Median Price
93.99
0.0704
0.025
0.0794
0.0022
0.0672
0.04
0.001
0.02
0.026
Price Action Indicator
(1.80)
0.0022
N/A
6.0E-4
(0.01)
(0)
N/A
N/A
N/A
(0)
Relative Strength Index
55.75
60.06
N/A
47.26
31.89
43.77
61.02
N/A
N/A
43.49
Coefficient Of Variation
(30,937)
2127.86
(606.16)
1965.93
(3,118)
(3,991)
1073.48
N/A
23740.06
(2,177)
Mean Deviation
1.08
6.55
0.8725
6.64
11.72
4.14
8.98
N/A
0.1514
5.1
Jensen Alpha
(0.07)
0.3389
(0.38)
0.4742
(0.80)
(0.10)
3.25
N/A
(0.01)
(0.36)
Total Risk Alpha
(0.14)
(0.54)
(0.58)
(0.40)
(3.42)
(0.75)
0.1762
N/A
(0.08)
(1.03)
Sortino Ratio
N/A
0.0534
N/A
0.0283
N/A
N/A
N/A
N/A
N/A
N/A
Downside Variance
N/A
96.69
N/A
255.27
N/A
N/A
N/A
N/A
N/A
N/A
Standard Deviation
1.42
12.77
2.27
10.37
28.3
6.56
37.95
N/A
0.8564
7.58
Kurtosis
1.13
24.22
20.91
0.3862
15.45
14.06
59.88
N/A
32.58
1.16
Potential Upside
2.05
14.29
N/A
22.22
28.62
7.5
N/A
N/A
N/A
12.84
Treynor Ratio
(0.02)
0.1524
37.3
0.7728
0.5201
0.1606
0.8241
N/A
(0.12)
(8.12)
Maximum Drawdown
7.45
100.78
18.63
40.4
246.96
48.18
300.0
N/A
9.76
35.98
Variance
2.02
163.15
5.15
107.59
801.06
42.98
1440.3
N/A
0.7335
57.39
Market Risk Adjusted Performance
(0.01)
0.1624
37.31
0.7828
0.5301
0.1706
0.8341
N/A
(0.11)
(8.11)
Risk Adjusted Performance
0.0025
0.044
(0.11)
0.0467
(0.01)
(0.01)
0.0783
N/A
0.0045
(0.02)
Skewness
(0.50)
3.9
(4.11)
0.1974
1.9
2.62
7.46
N/A
0.4169
0.1585
Semi Deviation
N/A
7.07
N/A
7.79
N/A
N/A
N/A
N/A
N/A
N/A
Information Ratio
(0.06)
0.0411
(0.20)
0.0436
(0.03)
(0.04)
0.0912
N/A
(0.08)
(0.06)
Value At Risk
(2.34)
(12.50)
N/A
(18.18)
(36.25)
(8.33)
N/A
N/A
N/A
(14.58)
Expected Short fall
N/A
(10.40)
N/A
(15.14)
N/A
N/A
N/A
N/A
N/A
N/A
Downside Deviation
N/A
9.83
N/A
15.98
N/A
N/A
N/A
N/A
N/A
N/A
Semi Variance
N/A
49.93
N/A
60.73
N/A
N/A
N/A
N/A
N/A
N/A

CochLear Competition Performance Charts

Five steps to successful analysis of CochLear Competition

CochLear's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by CochLear ADR in relation to its competition. CochLear's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of CochLear in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact CochLear's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to CochLear ADR, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your CochLear position

In addition to having CochLear in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run World Allocation Funds Thematic Idea Now

World Allocation Funds
World Allocation Funds Theme
Funds or Etfs investing in stocks, bonds, and cash of domestic markets as well as in markets of Canada, Japan, and Europe. The World Allocation Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize World Allocation Funds Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for CochLear Pink Sheet Analysis

When running CochLear's price analysis, check to measure CochLear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CochLear is operating at the current time. Most of CochLear's value examination focuses on studying past and present price action to predict the probability of CochLear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CochLear's price. Additionally, you may evaluate how the addition of CochLear to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY